A detailed history of Gouws Capital LLC transactions in Amgen Inc stock. As of the latest transaction made, Gouws Capital LLC holds 16,263 shares of AMGN stock, worth $5.41 Million. This represents 3.64% of its overall portfolio holdings.

Number of Shares
16,263
Previous 15,510 4.85%
Holding current value
$5.41 Million
Previous $4.41 Million 15.24%
% of portfolio
3.64%
Previous 3.34%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

BUY
$262.75 - $319.31 $197,850 - $240,440
753 Added 4.85%
16,263 $5.08 Million
Q1 2024

May 08, 2024

BUY
$268.87 - $324.56 $1.08 Million - $1.3 Million
4,005 Added 34.81%
15,510 $4.41 Million
Q4 2023

Jan 24, 2024

BUY
$255.7 - $288.46 $819,518 - $924,514
3,205 Added 38.61%
11,505 $3.31 Million
Q1 2023

May 09, 2023

SELL
$225.79 - $275.2 $248,369 - $302,720
-1,100 Reduced 11.7%
8,300 $2.01 Million
Q4 2021

Feb 03, 2022

BUY
$198.88 - $227.6 $1.87 Million - $2.14 Million
9,400 New
9,400 $2.12 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $178B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Gouws Capital LLC Portfolio

Follow Gouws Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gouws Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gouws Capital LLC with notifications on news.